ESR1 and Insulin resistance: Mouse models have shown that ERα signaling promotes metabolic flexibility in women and protects against obesity and metabolic dysfunction induced by a HFD [189], such as fatty liver, elevated circulating lipids, ectopic fat accumulation, impaired glucose tolerance, and insulin resistance, common in MetS and menopause [190].